GSK's cervical cancer vaccine Cervarix gains approval in Japan
Saturday, October 17, 2009 10:00 IST London
GlaxoSmithKline (GSK) gained approval for Cervarix in Japan, which becomes the first cervical cancer vaccine to be approved by the Japanese Ministry of Health, Labour and Welfare (MHLW).